Insider Cluster (3 insiders) ·Filed May 22, 2026

KURA

Kura Oncology, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago
Insider cluster: 3 insiders, $0.2M total
Actionable Insight • Neutral

This insider cluster is routine and lacks signal. No bearish read-through warranted at these dollar levels. Monitor institutional ownership changes in next 13F filing (Aug 2026) for real conviction shifts, and watch for clinical catalysts in KOMZIFTI's ongoing regulatory cycle.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
KURA ▲ +20.36% at T+60d
NEUTRAL call ✓ call won +20.36% · α vs SPY +17.64% · entry $10.41 → $12.53
Entry anchored
May 22, 03:59 PM ET
via exchange tick
T+1d
-0.19%
call -0.19% · α -0.15%
$10.39
settled 4mo ago
T+5d
-13.21%
call -13.21% · α -14.29%
$9.04
settled 4mo ago
T+20d
+2.69%
call +2.69% · α +4.64%
$10.69
settled 3mo ago
T+60d
+20.36%
call +20.36% · α +17.64%
$12.53
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Three KURA C-suite insiders (COO, CLO, CCO) sold a total of $152K in open-market sales over a 7-day window, occurring 10 days after Q1 earnings that beat revenue estimates but showed a widening net loss. At $152K against a ~$988M market cap (0.015% of market cap), the cluster is economically trivial and falls below the 0.1% proportionality threshold, making it a routine, non-informative event unlikely to signal a material bearish view. The C-suite weighting is neutralized by the sub-0.1% size and proximity to a blackout-window opening after earnings — the most common liquidity explanation for clustered sells.

Key Financial Metrics

Direction
selling
Total Value
$152.0K
Insiders
3

Key Facts

  • Three C-suite insiders sold: COO ($20K), CLO ($21K), CCO ($110K) — total $152K.
  • Cluster value is 0.015% of market cap ($988M), well below the 0.1% materiality floor.
  • Trades occurred 6-9 days after Q1 2026 earnings (May 12) — open blackout window pattern.
  • Per academic literature, cluster sells are not amplified; liquidity/vesting explanations dominate.
  • Q1 2026: $5.8M KOMZIFTI revenue beat consensus, but net loss widened to $73.3M from $57.4M YoY.

Financial Impact

Total insider sales of $152K — immaterial relative to $988M market cap (0.015%)

market_capinsider_activity

Risk Factors

  • Risk of over-interpreting small insider sells as directional signal — they are not.
  • KURA's cash burn remains high ($580.8M cash, but $73.3M quarterly loss); dilution risk persists.
  • Lack of any insider BUYS alongside funded pipeline adds mild caution but not actionable.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-KURA-1779480396005
21 reports for KURA
Performance horizon
83% Hit rate 10 of 12 directional calls best @ T+60▲ +52.28%Jun 3, 2026
Filters
Rows
Reports for KURA — sortable, filterable
TypeNow
Sep 9, 2026
23d ago
8-K
BULLISH ★ 6/10
$12.09 $11.37▼ −6.00%▼ −5.66%$10.65 (−11.91%)
Sep 8, 2026
24d ago
8-K
NEUTRAL ★ 2/10
$12.52 $11.30▼ −9.74%▼ −8.63%$10.65 (−14.94%)
Aug 24, 2026
5w ago
Insider Cluster
BULLISH ★ 6/10
$12.40 $12.65▲ +2.02%▲ +1.55%$10.65 (−14.11%)
Aug 21, 2026
6w ago
Insider Cluster
BULLISH ★ 6/10
$11.89 $12.66▲ +6.48%▲ +6.00%$10.65 (−10.43%)
Aug 17, 2026
6w ago
Insider Buy
BULLISH ★ 7/10
$12.33 $13.59▲ +10.22%▲ +10.42%$10.65 (−13.63%)
Aug 12, 2026
7w ago
Press Release
BULLISH ★ 6/10
$10.09 $11.71▲ +16.06%▲ +18.02%$10.65 (+5.55%)
Aug 5, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$9.20 $9.94▲ +8.04%▲ +7.69%$10.65 (+15.76%)
Jul 29, 2026
9w ago
8-K
NEUTRAL ★ 2/10
$9.31 $9.28▼ −0.32%▼ −3.94%$10.65 (+14.39%)
Jul 14, 2026
11w ago
Press Release
NEUTRAL ★ 5/10
$11.24 $10.68▼ −4.98%▼ −3.69%$10.65 (−5.25%)
Jun 3, 2026
17w ago
Press Release
BULLISH ★ 7/10
$8.66 $8.68▲ +0.29%▲ +4.11%$10.65 (+23.05%)
Showing 10 of 21

US Market Status

Market Closed — Opens Mon (64h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 22, 2026